Stock Earnings

Question 1

Redhill Biopharma Ltd'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Redhill Biopharma Ltd'in toplam varlıkları $18 olup, net loss $-8'dir.

Question 2

RDHL'ün temel finansal oranları nelerdir?

Accepted Answer

Redhill Biopharma Ltd'in cari oranı 0.81, net kâr marjı -100, hisse başına satış $0'dir.

Question 3

Redhill Biopharma Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Redhill Biopharma Ltd largest revenue segment is Commercial, at a revenue of 6,530,000 in the most earnings release.For geography, United States is the primary market for Redhill Biopharma Ltd, at a revenue of 6,530,000.

Question 4

Redhill Biopharma Ltd kârlı mı?

Accepted Answer

no, son mali tablolara göre Redhill Biopharma Ltd'in net loss $-8'dir.

Question 5

Redhill Biopharma Ltd'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Redhill Biopharma Ltd'in yükümlülüğü 22'dir.

Question 6

Redhill Biopharma Ltd'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Redhill Biopharma Ltd'in toplam tedavüldeki hisse sayısı 12,899.83'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	10	8	6	61	85	64
Revenue Growth (YoY)	-9%	33%	-90%	-28%	33%	967%
Cost of Revenue	4	3	3	33	40	36
Gross Profit	6	4	3	28	45	28
Selling, General & Admin	24	15	30	64	87	74
Research & Development	2	1	3	7	29	16
Operating Expenses	29	19	-9	71	117	91
Other Non Operating Income (Expenses)	--	-1	-1	0	0	0
Pretax Income	-11	-8	23	-71	-97	-76
Income Tax Expense	--	--	--	--	--	--
Net Income	-11	-8	23	-71	-97	-76
Net Income Growth	-114.99%	-135%	-132%	-27%	28%	81%
Shares Outstanding (Diluted)	12,322.72	12,322.72	103.64	619.3	465.27	364.28
Shares Change (YoY)	11,789%	11,789%	-83%	33%	28%	23%
EPS (Diluted)	0	0	0.23	-0.12	-0.21	-0.21
EPS Growth	-100%	-100%	-292%	-43%	0%	50%
Free Cash Flow	-9	-9	-35	-29	-65	-102
Free Cash Flow Per Share	0	0	-0.33	-0.04	-0.13	-0.28
Gross Margin	60%	50%	50%	45.9%	52.94%	43.75%
Operating Margin	-229.99%	-175%	200%	-68.85%	-84.7%	-96.87%
Profit Margin	-110%	-100%	383.33%	-116.39%	-114.11%	-118.75%
Free Cash Flow Margin	-90%	-112.5%	-583.33%	-47.54%	-76.47%	-159.37%
EBITDA	-23	-14	13	-34	-54	-54
EBITDA Margin	-229.99%	-175%	216.66%	-55.73%	-63.52%	-84.37%
D&A For EBITDA	0	0	1	8	18	8
EBIT	-23	-14	12	-42	-72	-62
EBIT Margin	-229.99%	-175%	200%	-68.85%	-84.7%	-96.87%
Effective Tax Rate	--	--	--	--	--	--

Redhill Biopharma Ltd (RDHL) Price

RDHL Stock Price Chart

RDHL Income

Follow-Up Questions